Compositing is limited to 5 or less “like” samples and does not occur in areas with a recent history of positives. A separate sponge is used for each site. Compositing methods are validated to ensure
The EMP takes into account facility conditions. Cold or wet areas are sampled for Listeria spp. In addition program leadership actively seeks the newest information about Lm risk conditions and detection so the EMP is consistent with industry practices.
EMP sites and quantities are selected based on zones, drain locations/quantities, equipment/plant layouts as it relates to Lm risks. Quantities are based on facility size, equipment amount, layout and workflow. A site map is used to define
EMP is designed to seek and destroy Lm. The EMP team conducts a robust risk assessment that will lead to the determination of the sampling locations, timing and frequency of samplings. The assessment should include (at
EMP samples are collected at least weekly and include samples at eye level, below and above. Greater than 55 swabs are taken per 50,000 sq. ft. per week. (should be focused on risk assessments). As
For all media inquiries, please contact:
Mary Emma Young
Vice President of Communications
meyoung@affi.com
443-904-3937
Tel: (703) 821.0770
Email: info@affi.com